RECURSION PHARMACEUTICALS, INC. (RXRX) › Operating Cash FlowRECURSION PHARMACEUTICALS, INC. (RXRX) — Operating Cash FlowAnnual figures by fiscal year, from SEC filings.2019: -$57.04M2020: -$45.40M2021: -$158.61M2022: -$83.52M2023: -$287.78M2024: -$359.17M2025: -$371.81M-$371.81M2019Operating Cash Flow (USD)2025Fiscal YearOperating Cash FlowChange YoY2025-$371.81M-3.5%2024-$359.17M-24.8%2023-$287.78M-244.5%2022-$83.52M+47.3%2021-$158.61M-249.4%2020-$45.40M+20.4%2019-$57.04M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsCapital ExpendituresShares OutstandingDividends Per Share